Edgewise Therapeutics, Inc.

NASDAQ:EWTX

25.28 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -133.813-100.163-67.64-42.813-17.123-9.705
Depreciation & Amortization 2.291.7320.5380.2720.1850.123
Deferred Income Tax 000-2.294-0.203-0.048
Stock Based Compensation 24.71217.5610.9244.4040.3540.077
Change In Working Capital 10.328-1.564.0864.631.950.334
Accounts Receivables 000000
Inventory 000000
Accounts Payables 1.737-0.0920.0472.6540.5210.275
Other Working Capital 8.591-1.4684.0391.9761.4290.059
Other Non Cash Items -12.545-9.517-0.5432.2940.2030.048
Operating Cash Flow -109.028-91.948-52.635-33.507-14.634-9.171
Investing Activities:
Investments In Property Plant And Equipment -1.312-5.745-5.546-0.668-0.203-0.18
Acquisitions Net 000.0650.24200
Purchases Of Investments -477.055-255.866-292.388-288.203-24.1780
Sales Maturities Of Investments 293.711364.497227.35746.64400
Other Investing Activites 00-0.065-0.242-0.0240
Investing Cash Flow -184.656102.886-70.577-242.227-24.381-0.18
Financing Activities:
Debt Repayment 000000
Common Stock Issued 239.14752.618129.165186.148120.27824.8
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 10.1061.2610.4740.236120.27824.8
Financing Cash Flow 249.25353.166129.639186.384120.27824.8
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -44.43164.1046.427-89.3581.26315.449
Cash At End Of Period 41.66686.09721.99315.566104.91623.653